| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 06/28/2007 | WO2007072999A1 Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same |
| 06/28/2007 | WO2007071952A1 Piperazine compounds useful as antagonists of c-c chemokines (ccr2b and ccr5) for the treatment of inflammatory diseases |
| 06/28/2007 | WO2007071646A1 Novel substituted pyrazinone derivatives for use in mch-1 mediated diseases |
| 06/28/2007 | WO2007071400A1 Pyrazine derivatives as epithelial sodium channel blocker |
| 06/28/2007 | US20070149545 Substituted indan derivatives |
| 06/28/2007 | US20070149544 Biaryl nitrogen-heterocycle inhibitors of lta4h for treating inflammation |
| 06/28/2007 | US20070149536 2-[4-Bromomethyl)phenyl-3-phenylquinoxaline 1-2; selectively inhibits one or two of the serine/threonine protein kinase isoforms; antiproliferative |
| 06/28/2007 | CA2633207A1 Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same |
| 06/28/2007 | CA2630889A1 Pyrazine derivatives as epithelial sodium channel blocker |
| 06/28/2007 | CA2626220A1 Novel substituted pyrazinone derivatives for use in mch-1 mediated diseases |
| 06/27/2007 | EP1799646A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 06/27/2007 | EP1278721B1 Process for the preparation of pyrazine compounds |
| 06/26/2007 | US7235662 useful in treating diseases requiring glucocorticoid receptor agonist or antagonist therapy such as obesity, diabetes and inflammatory or immune associated diseases |
| 06/26/2007 | US7235554 Water soluble; treating diseases in which peripheral benzodiazepine receptors are involved such as spinal amyotrophy, amyotrophic lateral sclerosis, cranial and medullar trauma, multiple sclerosis, and diabetic nephropathy |
| 06/26/2007 | US7235549 Benzamide, heteroarylamide and reverse amides |
| 06/21/2007 | WO2007070760A2 Compounds which modulate the cb2 receptor |
| 06/21/2007 | WO2007069978A1 Novel n-(fluoro-pyrazinyl)-phenylsulfonamid.es as moodulators of chemokine receptor ccr4. |
| 06/21/2007 | WO2007041365A3 3-cyclyl-2- (4-sulfamo yl-phenyl) -n-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes |
| 06/21/2007 | WO2007003604A3 Hists1mine h3 receptor antagonists |
| 06/21/2007 | US20070142399 Dual function drugs and uses thereof |
| 06/21/2007 | US20070142393 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 06/21/2007 | US20070142391 Piperazine-2-carboxamide derivatives |
| 06/21/2007 | US20070142388 Inhibitors of Akt activity |
| 06/21/2007 | US20070142381 Calcium receptor modulating agents |
| 06/21/2007 | US20070142333 Cycloalkyl inhibitors of potassium channel function |
| 06/21/2007 | CA2632030A1 Compounds which modulate the cb2 receptor |
| 06/21/2007 | CA2631342A1 Novel n-(fluoro-pyrazinyl)-phenylsulfonamid.es as moodulators of chemokine receptor ccr4. |
| 06/20/2007 | EP1798223A2 Aryl sulfonamides |
| 06/20/2007 | EP1797100A1 Nitrate esters and their use for mitigating cellular damage |
| 06/20/2007 | EP1797073A2 Bicyclic anilide spirolactam cgrp receptor antagonists |
| 06/20/2007 | EP1797065A2 Acyclic 1,3-diamines and uses therefor |
| 06/20/2007 | EP1797052A1 Bicyclic compounds which inhibit beta-secretase activity and methods of use thereof |
| 06/20/2007 | EP1797036A1 Sigma receptor ligands |
| 06/20/2007 | EP1796669A2 Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 06/20/2007 | EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 06/20/2007 | CN1984892A Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| 06/20/2007 | CN1984655A Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| 06/19/2007 | US7232821 (2-((2-alkoxy)-phenyl) -cyclopent-1enyl) aromatic carbo and heterocyclic acid and derivatives |
| 06/19/2007 | US7232616 Complex |
| 06/14/2007 | WO2007067629A1 Bradykinin 1 receptor antagonists |
| 06/14/2007 | WO2007066556A1 Organometallic complex and light-emitting element, light-emitting device and electronic device using the same |
| 06/14/2007 | US20070135633 producing pyridine-substituted indole compound by reacting an indole with pyridine having leaving group, in presence of heterogeneous-system platinum group metal catalyst on support, ligand (1,1'-bis(diphenylphosphino)ferrocene) and base; industrial scale, cost efficiency |
| 06/14/2007 | US20070135449 Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexanols |
| 06/14/2007 | US20070132372 Amine based compound and organic electroluminescence device using the same |
| 06/14/2007 | CA2631037A1 Bradykinin 1 receptor antagonists |
| 06/13/2007 | EP1214292B1 Tyrosine derivatives |
| 06/13/2007 | CN1980909A Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
| 06/13/2007 | CN1980900A Sulfoderivatives of indanthrone, lyotropic liquid crystal system and anisotropic film on their base |
| 06/13/2007 | CN1980892A Dpp-IV inhibitors |
| 06/13/2007 | CN1980662A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
| 06/13/2007 | CN1978439A Star-shaped oligothiophene-arylene derivatives and organic thin film transistors using the same |
| 06/13/2007 | CN1321115C Piperazine derivatives for use as CCR-3 receptor antagonists in the treatment of asthma |
| 06/12/2007 | US7230020 For therapy of metabolic disorders, such as diabetes and obesity, cardiovascular disorders, such as hypertension, glaucoma, inflammatory disorders, such as arthritis or asthma, immune disorders, bone disorders, such as osteoporosis, cancer |
| 06/12/2007 | US7230003 Aromatic prodrugs of propofol, compositions and uses thereof |
| 06/12/2007 | US7229992 Process for the preparation of a piperazine derivative |
| 06/12/2007 | US7229988 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants |
| 06/07/2007 | WO2007063934A1 Alicyclic heterocyclic compound |
| 06/07/2007 | WO2006074147A3 Nitrogen containing bicyclic compounds and therapeutical use thereof |
| 06/07/2007 | US20070129378 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | US20070129377 Process for Preparing Substituted Aryl Cycloalkanol Derivatives |
| 06/07/2007 | US20070129375 6-Substituted 2-quinolinones and 2-quinoxalinones as poly (adp-ribose) polymerase inhibitors |
| 06/07/2007 | US20070126345 Halogenated bisdiarylaminopolycylic aromatic compounds and polymers thereof |
| 06/06/2007 | EP1791536A1 1-[(3r)-amino-4-(2-fluoro-phenyl)-butyl]-pyrrolidine-(2r)-carboxylic acid-benzyl amine derivatives and related compounds as dipeptidyl-peptidase iv (dpp-iv) inhibitors for the treatment of type 2 diabetes mellitus |
| 06/06/2007 | CN1976892A Substituted enaminones, their derivatives and uses thereof |
| 06/06/2007 | CN1976707A 3-aminocyclopentanecarboxamides as modulators of chemotactic factor receptors |
| 06/06/2007 | CN1974560A Compound 3-isopropyl-6-(2-methylbutyl) piperazine-2,5-dione and its prepn and application |
| 06/06/2007 | CN1319973C Piperidine derivatives |
| 06/06/2007 | CN1319958C Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 06/05/2007 | USRE39680 Sleep disorders associated with 5-HT2A serotonin receptor modulation; antagonists or agonists |
| 06/05/2007 | US7227035 Bis-aryl sulfonamides |
| 06/05/2007 | US7227022 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |
| 06/05/2007 | US7226925 Compounds, their use and preparation |
| 06/05/2007 | CA2269561C Naphthalene derivative and liquid crystal composition comprising the same |
| 05/31/2007 | WO2007060795A1 Amine compound and organic electroluminescent element employing the same |
| 05/31/2007 | WO2007060132A1 N-hydroxyamide derivatives and use thereof |
| 05/31/2007 | WO2007042848A3 Process for the preparation of carbidopa |
| 05/31/2007 | WO2007041077A3 Heterocyclic amide derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 05/31/2007 | US20070123542 Substituted [4-(4-phenyl-piperazin-1-yl)-cyclohexyl]-urea compounds |
| 05/31/2007 | US20070123532 Piperazine derivatives |
| 05/31/2007 | CA2630551A1 N-hydroxyamide derivatives and use thereof |
| 05/30/2007 | EP1789410A1 Methylene dipiperidine derivatives |
| 05/30/2007 | EP1789396A1 Substituted phenylacetamides and their use as glucokinase activators |
| 05/30/2007 | EP1789050A1 Novel quinoxalinone norepinephrine reuptake inhibitors for the treatment of central nervous system disorders |
| 05/30/2007 | EP1789049A2 Cyclic amide and ester pyrazinoylguanidine sodium channel blockers |
| 05/30/2007 | EP1789044A1 Phenylaminopyridines |
| 05/30/2007 | EP1562940B1 Aryl sulfonamides |
| 05/30/2007 | CN1972914A Non-imidazole heterocyclic compounds as histamine H3-receptor ligands |
| 05/30/2007 | CN1970538A 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 05/30/2007 | CN1318424C Aromatic heterocyclic carboxylic derivative, preparing method and use on medicine |
| 05/29/2007 | US7223868 Heteroaromatic glucokinase activators |
| 05/29/2007 | US7223774 Benzamide 2-hydroxy-3-diaminoalkanes |
| 05/29/2007 | US7223763 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 05/29/2007 | US7223762 Bind to Very Late Antigen-4 (VLA-4); treating asthma; 3-(5-(2-Methylphenyl)-2-(N-cyclohexyl-N-methylamino)pyrimidin-4-ylamino)-3-(4-(dimethylaminocarbonyl)oxyphenyl)propanoic Acid for example |
| 05/29/2007 | US7223751 Sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same |
| 05/24/2007 | WO2007058336A1 SCREENING METHOD AND IDENTIFICATION METHOD FOR SUBSTANCE CAPABLE OF INHIBITING DEGRANULATION REACTION OR PROSTAGLANDIN D2 PRODUCTION IN MAST CELL THROUGH Rec168, AND THERAPEUTIC AGENT FOR INFLAMMATORY DISEASE COMPRISING THE SUBSTANCE |
| 05/24/2007 | WO2007057687A1 Piperazine derivatives and their use in therapy |
| 05/24/2007 | WO2006128173A3 Selective apoptotic induction in cancer cells including activation of procaspase-3 |
| 05/24/2007 | US20070117811 N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-phenyl-1-piperazinealkylamide derivatives, and therapeutic use thereof as 5-HT7 receptor ligands |
| 05/24/2007 | US20070117805 Modulators and steroid receptors for treatment of diabetes, inflammatory diseases using prodrugs; arthritis, asthma, rhinitis and immunomodulation |
| 05/23/2007 | EP1786786A1 Adamantyl derivates as p2x7 receptor antagonists |